alendronate has been researched along with exudates in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SP; Othman, AZ; Yeap, SS; Zain, AA | 1 |
| Chan, SP; Chua, SS; Lai, PS | 1 |
| Chan, SP; Chong, YH; Chua, SS; Lai, PS | 1 |
| Choo, YW; Li, SC; Makmor Bakry, M; Mohamed Said, MS; Mohd Tahir, NA | 1 |
1 review(s) available for alendronate and exudates
| Article | Year |
|---|---|
Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Cost-Benefit Analysis; Denosumab; Female; Humans; Malaysia; Middle Aged; Osteoporosis, Postmenopausal; Quality-Adjusted Life Years | 2022 |
2 trial(s) available for alendronate and exudates
| Article | Year |
|---|---|
Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids.
Topics: Absorptiometry, Photon; Adrenal Cortex Hormones; Adult; Alendronate; Asian People; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcitriol; Calcium; Dietary Supplements; Female; Humans; Lupus Erythematosus, Systemic; Malaysia; Osteoporosis; Premenopause; Time Factors; Treatment Outcome; Vitamin D; Young Adult | 2012 |
Pharmaceutical care issues encountered by post-menopausal osteoporotic women prescribed bisphosphonates.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Malaysia; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Outcome Assessment, Health Care; Patient Satisfaction; Pharmaceutical Services; Quality of Life; Risedronic Acid | 2012 |
1 other study(ies) available for alendronate and exudates
| Article | Year |
|---|---|
The effect of mandatory generic substitution on the safety of alendronate and patients' adherence.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Data Collection; Drug Substitution; Female; Humans; Interviews as Topic; Malaysia; Mandatory Programs; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance | 2012 |